Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Article En | MEDLINE | ID: mdl-31108178

We have investigated the effect of the local activation of histamine H3 receptors (H3Rs) in the rat prefrontal cortex (PFCx) on the impairment of pre-pulse inhibition (PPI) of the startle response induced by the systemic administration of MK-801, antagonist at glutamate N-Methyl-d-Aspartate (NMDA) receptors, and the possible functional interaction between H3Rs and MK-801 on PFCx dopaminergic transmission. Infusion of the H3R agonist RAMH (19.8 ng/1 µl) into the PFCx reduced or prevented the inhibition by MK-801 (0.15 mg/kg, ip) of PPI evoked by different auditory stimulus intensities (5, 10 and 15 dB), and the RAMH effect was blocked by the H3R antagonist/inverse agonist ciproxifan (30.6 ng/1 µl). MK-801 inhibited [3H]-dopamine uptake (-45.4 ±â€¯2.1%) and release (-32.8 ±â€¯2.6%) in PFCx synaptosomes or slices, respectively, and molecular modeling indicated that MK-801 binds to and blocks the rat and human dopamine transporters. However, H3R activation had no effect on the inhibitory action of MK-801 on dopamine uptake and release. In PFCx slices, MK-801 and the activation of H3Rs or dopamine D1 receptors (D1Rs) stimulated ERK-1/2 and Akt phosphorylation. The co-activation of D1Rs and H3Rs prevented ERK-1/2 and Akt phosphorylation, and H3R activation or D1R blockade prevented the effect of MK-801. In ex vivo experiments, the intracortical infusion of the D1R agonist SKF-81297 (37 ng/1 µl) or the H3R agonist RAMH increased Akt phosphorylation, prevented by D1R/H3R co-activation. These results indicate that MK-801 enhances dopaminergic transmission in the PFCx, and that H3R activation counteracts the post-synaptic actions of dopamine.


Dizocilpine Maleate/pharmacology , Prepulse Inhibition/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Histamine H3/metabolism , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Reflex, Startle/drug effects , Animals , Benzazepines/administration & dosage , Benzazepines/pharmacology , Dizocilpine Maleate/administration & dosage , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Excitatory Amino Acid Antagonists/pharmacology , Histamine Agonists/administration & dosage , Histamine Agonists/pharmacology , Imidazoles/administration & dosage , Imidazoles/pharmacology , Male , Microinjections , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Molecular Docking Simulation , Phosphorylation/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Tritium/metabolism
2.
Metab Brain Dis ; 33(1): 99-105, 2018 02.
Article En | MEDLINE | ID: mdl-29052075

Dopamine (DA) modulates motor coordination, and its depletion, as in Parkinson's disease, produces motor impairment. The basal ganglia, cerebellum and cerebral cortex are interconnected, have functional roles in motor coordination, and possess dopamine D1 receptors (D1Rs), which are expressed at a particularly high density in the basal ganglia. In this study, we examined whether the activation of D1Rs modulates motor coordination and balance in the rat using a beam-walking test that has previously been used to detect motor coordination deficits. The systemic administration of the D1R agonist SKF-38393 at 2, 3, or 4 mg/kg did not alter the beam-walking scores, but the subsequent administration of the D1R antagonist SCH-23390 at 1 mg/kg did produce deficits in motor coordination, which were reversed by the full agonist SKF-82958. The co-administration of SKF-38393 and SCH-23390 did not alter the beam-walking scores compared with the control group, but significantly prevented the increase in beam-walking scores induced by SCH-23390. The effect of the D1R agonist to prevent and reverse the effect of the D1R antagonist in beam-walking scores is an indicator that the function of D1Rs is necessary to maintain motor coordination and balance in rats. Our results support that D1Rs mediate the SCH-23390-induced deficit in motor coordination.


Corpus Striatum/drug effects , Dopamine Agonists/pharmacology , Motor Activity/drug effects , Parkinson Disease/drug therapy , Receptors, Dopamine D1/drug effects , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Benzazepines/pharmacology , Male , Postural Balance/drug effects , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism
3.
Brain Struct Funct ; 218(2): 437-53, 2013 Mar.
Article En | MEDLINE | ID: mdl-22481229

The adult brain is highly plastic and tends to undergo substantial reorganization after injury to compensate for the lesion effects. It has been shown that such reorganization mainly relies on anatomical and biochemical modifications of the remaining cells which give rise to a network rewiring without reinstating the original morphology of the damaged region. However, few studies have analyzed the neurorepair potential of a neurogenic structure. Thus, the aim of this work was to analyze if the DG could restore its original morphology after a lesion and to establish if the structural reorganization is accompanied by behavioral and electrophysiological recovery. Using a subepileptogenic injection of kainic acid (KA), we induced a focal lesion in the DG and assessed in time (1) the loss and recovery of dependent and non dependent DG cognitive functions, (2) the anatomical reorganization of the DG using a stereological probe and immunohistochemical markers for different neuronal maturation stages and, (3) synaptic plasticity as assessed through the induction of in vivo long-term potentiation (LTP) in the mossy fiber pathway (CA3-DG). Our results show that a DG focal lesion with KA leads to a well delimited region of neuronal loss, disorganization of the structure, the loss of associated mnemonic functions and the impairment to elicit LTP. However, behavioral and synaptic plasticity expression occurs in a time dependent fashion and occurs along the morphological restoration of the DG. These results provide novel information on neural plasticity events associated to functional reorganization after damage.


Cognition/drug effects , Dentate Gyrus/drug effects , Excitatory Amino Acid Agonists/toxicity , Kainic Acid/toxicity , Neuronal Plasticity/drug effects , Synapses/drug effects , Animals , Behavior, Animal/drug effects , Biomarkers/metabolism , Dentate Gyrus/metabolism , Dentate Gyrus/pathology , Dentate Gyrus/physiopathology , Excitatory Postsynaptic Potentials/drug effects , Fear/drug effects , Immunohistochemistry , Long-Term Potentiation/drug effects , Male , Memory/drug effects , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/pathology , Mossy Fibers, Hippocampal/physiopathology , Motor Activity/drug effects , Rats , Rats, Wistar , Recovery of Function , Synapses/metabolism , Synapses/pathology , Time Factors
...